Clinical trials
Terminated Phase 1/2 Immune System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AO GENERIUM | 1 |
| Alladapt Immunotherapeutics, Inc. | 1 |
| Celgene | 1 |
| Celularity Incorporated | 1 |
| Inmagene LLC | 1 |
| Intellia Therapeutics | 1 |
| Jasper Therapeutics, Inc. | 1 |
| Oncternal Therapeutics, Inc | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 9 |
| Immunoproliferative Disorders | 3 |
| Leukemia | 3 |
| Lymphatic Diseases | 3 |
| Lymphoproliferative Disorders | 3 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Skin Diseases | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.